Biotech Startups

Secretome Therapeutics is a biotechnology company advancing therapeutic programs through research, development, and clinical operations.

1 investor

The Wadsworth Center is a public health laboratory operated by the New York State Department of Health, providing diagnostic testing (including coronavirus and mpox testing) and health-related research. It serves public health and clinical laboratory needs in New York State.

1 investor

SEED Therapeutics develops de novo molecular glue degraders for targeted protein degradation, using its RITE3 platform to match E3 ligases with disease-causing target proteins. Its lead RBM39 degrader (ST-01156) is in Phase 1 trials for Ewing sarcoma, hepatocellular carcinoma and related tumors, alongside additional oncology programs.

1 investor

Seegene is a molecular diagnostics company; this page is its investor relations section listing quarterly earnings release IR books available for download.

1 investor

Seelos Therapeutics is a biopharmaceutical company based in New York. The page provides corporate and legal details but limited information about its specific therapeutic focus.

1 investor

Segra International is an agricultural technology company that develops tissue culture and genetic solutions for the global cannabis industry. The company combines plant biotechnology expertise with horticultural operations to support cannabis producers internationally.

1 investor

Markoma Women Farmer Producer Company is a farmer producer organization (FPO) of over 460 vegetable growers in Rayagada, Odisha, India, supported by Harsha Trust. The FPO operates a solar-powered 5 MT cold storage facility that serves both member farmers and local vendors, enabling produce preservation and stabilized market access at a fixed rental rate of INR 2 per kg.

1 investor

Semdor Pharma Group is a pharmaceutical full-service company for controlled substances (Betäubungsmittel) and medical cannabis, serving European wholesalers, suppliers, and pharmacies. It combines several specialist subsidiaries covering import, storage, logistics, packaging, marketing, online delivery, and digital infrastructure for the medical cannabis and narcotics market.

1 investor

Senara develops cell-based milk through biotechnology for the dairy industry, offering a sustainable alternative to traditional dairy production. The company targets consumers seeking ethical and environmentally responsible food choices.

1 investor

Senesys.Bio develops NanoJAGGs, a nanostructure-based delivery platform that targets and eliminates senescent cells to treat age-related and chronic diseases. The nanostructures selectively localize to senescent cells and can be configured to carry a range of therapeutic molecules, including senolytics, antioxidants, small drugs, and biomolecules.

1 investor

Senex Biotechnology develops cancer and chronic disease therapies by targeting aging-related biological pathways identified through functional genomics. The company focuses on oncology indications including ovarian, breast, and prostate cancers.

1 investor

Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan. The company operates three subsidiaries spanning longevity therapeutics (Eos Senolytix), oncology peptides (Perseus Senolytix), and controllable gene therapies (Phoenix Senolytix).

1 investor

Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs). The compound aims to improve on existing therapies like Epidiolex through better pharmacokinetics, reduced liver accumulation, and fewer drug-drug interactions.

1 investor

1 investor

Faeth Therapeutics is a biotech developing PIKTOR, an all-oral combination therapy that inhibits multiple nodes of the PAM (PI3K/AKT/mTOR) oncogenic pathway. It focuses on cancer treatments, with programs in endometrial cancer and HR+/HER2- breast cancer.

1 investor

SensID GmbH develops and manufactures reference materials and quality controls for DNA diagnostics. The company serves laboratory and diagnostic instrument developers who need precisely characterized materials for research, validation, accreditation, and conformity testing.

1 investor

Sensocure develops implantable microsensor technology to monitor tissue oxygen levels and detect ischemic events before irreversible damage occurs. The Norwegian medical device company targets clinical applications in tissue monitoring and prevention of ischemic injury.

1 investor

Sensoreal develops portable diagnostic tools for detecting marine biotoxins in shellfish, enabling real-time on-site testing to protect public health and support the seafood industry. The company serves shellfish harvesters, processors, and regulatory laboratories with rapid lateral flow assays for detecting paralytic, amnesic, and diarrhetic shellfish poisoning toxins.

1 investor

SensTek Diagnostics develops a solid-state molecular testing platform that enables rapid bacterial, fungal, and viral diagnostics across clinical, agricultural, water, and food safety applications. The company targets improved access to accurate diagnostics for communities underserved by traditional laboratory infrastructure.

1 investor

Bough Bio develops therapies that target senescent cells in the brain to treat neurological and psychiatric diseases. The company focuses on clearing damaged cells to restore healthy brain function and address conditions related to stress-induced brain damage.

1 investor

Sentara Group (formerly Nutrition Technologies) produces protein, oil, and organic fertilizer from Black Soldier Fly larvae using a zero-waste tropical production model, serving the pet food, livestock, and aquaculture feed sectors. Founded in 2015 in Vietnam, it operates a production plant, laboratory, and office in Johor Bahru, Malaysia and ships to Asia, Europe, and South America.

1 investor

1 investor

Sentinal4D develops interpretable machine learning tools for analyzing 3D and 4D cell morphology in drug discovery and mechanistic biology. PointMIL is a framework that classifies static 3D cell point clouds while providing point-level explanations of model predictions, enabling scientists to see where on the cell surface the model finds evidence for biological conclusions.

1 investor

A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.

1 investor